The COVID-19 pandemic magnified the importance of digital advances as companies raced to meet the demand for new testing, vaccines, and treatments to combat the pandemic. However, with increased competition, a shifting regulatory landscape and growing demands from patients and health care providers, life sciences companies face significant challenges and must find ways to differentiate themselves and remain competitive.
Our 2023 Global Life Sciences Outlook explores seven trends that are expected to shape the sector. In the coming year, the focus will remain on embracing digital technologies, navigating a changing regulatory landscapes and market volatility, and addressing health inequities. By adopting the right strategies and capabilities, life sciences companies can continue to deliver value to patients, health care providers and other stakeholders.